Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
08/2001
08/02/2001WO2000066175A3 Conjugates as therapies for cancer and prostate diseases
08/02/2001US20010011139 Polynucleotides labeled with dibenzorhodamine dyes
08/02/2001CA2395447A1 Palatable arginine compounds and uses thereof for cardiovascular health
08/01/2001EP1120412A1 Processes for the preparation of 4-substituted benzopyran derivatives
08/01/2001EP1120114A2 Compositions and methods for treating conditions responsive to estrogen
08/01/2001EP1119639A1 7-alkoxycoumarins as cyp2c9 substrates
08/01/2001EP1119560A1 Naphthopyrans annelated in c5-c6, their preparation and compositions and (co) polymer matrices containing them
08/01/2001EP1119559A1 3-phenyl-pyrones
08/01/2001EP1119554A1 Xanthan-ester and acridan substrates for horseradish peroxidase
08/01/2001EP1119353A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin
08/01/2001EP1119350A2 Rar antagonists as male anti-fertility agents
08/01/2001CN1306508A Hydroxamic acid derivatives as inhibitors or prodn. of human CD23 and of TNF release
07/2001
07/26/2001WO2001053285A1 Food product and process
07/26/2001WO2001053266A1 Therapeutic morpholino-substituted compounds
07/26/2001WO1999015129A3 SELECTIVE cPLA2 INHIBITORS
07/26/2001US20010009965 Novel analgesic and immunomodulatory cannabinoids
07/26/2001CA2397565A1 Food product and process
07/25/2001EP1118665A1 Recombinant production of aromatic polyketides
07/25/2001EP1118323A2 Method of reducing morbidity and the risk of mortality
07/25/2001EP1117801A2 Polyketide synthase enzymes and recombinant dna constructs therefor
07/25/2001EP1117656A1 Grey colouring photochromic fused pyrans
07/25/2001EP1117628A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
07/25/2001EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
07/25/2001CN1304934A Antineoplastic medicine and its preparing process
07/24/2001US6265612 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
07/24/2001US6265421 Phospholamban inhibitors and a method for increasing coronary flow
07/24/2001CA2155127C Process for the preparation of substituted 4-hydroxycoumarins
07/19/2001WO2001051483A1 Substituted photochromic 2h-naphtho [1,2-b] pyran compounds
07/19/2001WO2001051482A1 Extraction of flavonoids
07/19/2001WO2001051048A1 Use of epigallocatechin-gallate for inhibiting angiogenesis
07/19/2001CA2366621A1 Use of epigallocatechin-gallate for inhibiting angiogenesis
07/18/2001EP1116720A1 Processes for the preparation of isochromanones and intermediates for the preparation thereof
07/18/2001EP1115718A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
07/18/2001EP1115717A1 3-(hydroxymethyl)chromen-4-ones and process for their preparation
07/18/2001EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors
07/18/2001EP1115398A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
07/18/2001EP1115397A1 Method of mitigating the adverse effects of interleukin-2
07/18/2001EP0906304B1 Process for preparing 3-isochromanone
07/18/2001CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
07/18/2001CN1303853A Process for concentrating catechin solution
07/17/2001US6262279 Preparation of tocopherols
07/17/2001US6262270 Hydroxyphenylacetophenone derivative is reacted with n-ethoxybenzyl piperidine compound in presence of piperidine and hindered amine base and alkanol to produce pure antiestrogen compound
07/17/2001US6262108 Treating rheumatic diseases; and allergic, contact and atopic dermatitis
07/17/2001US6262083 Genipin derivative having liver protection activity
07/17/2001US6261565 Plant extract
07/17/2001CA2160961C New tricyclic amide compounds, process for preparing the same and pharmaceutical compositions containing them
07/12/2001WO2001049675A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders
07/12/2001WO2001049673A2 Compounds and methods for modulation of estrogen receptors
07/12/2001WO2001049649A1 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process
07/12/2001WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters
07/12/2001CA2475413A1 Compositions and methods for treating conditions responsive to estrogen
07/12/2001CA2475393A1 Compositions and methods for treating conditions responsive to estrogen
07/12/2001CA2396059A1 Compounds and methods for modulation of estrogen receptors
07/12/2001CA2395795A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders
07/12/2001CA2394184A1 Methods and compositions for mitigating pain using nitrate esters
07/12/2001CA2392832A1 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process
07/12/2001CA2331059A1 Method of reducing morbidity and the risk of mortality
07/11/2001EP1114821A1 Benzopyrans and their use as therapeutic agents
07/11/2001EP1114043A1 Naphthopyrans annelated in c 6?-c 7?, their preparation and compositions and (co)polymer matrices containing them
07/11/2001EP1114042A1 Process for preparing 3-isochromanone
07/11/2001EP1114041A1 Method for preparing vitamin e
07/11/2001EP1113791A2 Bioflavonoid as blood glucose level lowering agent
07/11/2001EP0725779B1 Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
07/11/2001CN1302800A Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
07/10/2001US6258840 Analogues or derivatives of quercetin (prodrugs)
07/10/2001US6258837 Antagonist in mammals for neuropeptides
07/10/2001US6258574 Stereospecifically esterifying a racemic mixture of cis-substituted tetrahydropyran-4-ol using esterase
07/05/2001WO2001047899A1 Substituted piperazine derivatives as mtp inhibitors
07/05/2001WO2001047891A1 Heterocyclic compounds having sulfonamide groups
07/05/2001US20010006978 Flavanone derivatives and composition for preventing or treating blood lipid level-related diseases comprising same
07/05/2001DE19963235A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments
07/05/2001CA2394644A1 Substituted piperazine derivatives,the preparation thereof and their useas medicaments
07/04/2001EP1112264A1 Polyalkoxylated naphthopyrans
07/04/2001EP1112263A1 Polymerizable polyalkoxylated naphthopyrans
07/04/2001EP0634927B1 Treatment and prophylaxis of diseases caused by parasites, or bacteria
07/04/2001CN1302295A Synthetic methods for polyphenols
07/04/2001CN1301698A Method for separating catechin monomer from tea extration
07/04/2001CN1067991C Aminoalkyl substituted benzo-heterocyclic compounds
07/03/2001US6255497 Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse
07/03/2001US6255496 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
07/03/2001US6255342 Pesticides
07/03/2001US6255324 Amino-and mercurio-substituted 4′,5'-dihydropsoralens and therapeutical uses thereof
07/03/2001CA2006222C Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers
06/2001
06/28/2001WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
06/28/2001WO2001045663A2 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION
06/28/2001US20010005753 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
06/28/2001CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
06/28/2001CA2363837A1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition
06/27/2001EP1109802A1 Spirofluorenopyrans
06/27/2001EP1109801A1 Substituted dihydrobenzopyrans useful as antiarrhythmic agents
06/27/2001EP1109800A1 Novel cdk inhibitors having flavone structure
06/27/2001EP1109544A1 Potassium channel inhibitors and method
06/27/2001CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists
06/26/2001US6252090 Compounds having activity as inhibitors of cytochrome P450RAI
06/26/2001US6252071 Aminomethylation of tocopherols
06/26/2001US6252042 Reacting peptide and protein with complex
06/26/2001US6251948 Trisubstituted guanidine useful for treating diseases of the nervous system in which the pathophysiology of the disease involves excessive excitation of nerve cells by agonists of glutamate/n-methyl-d-aspartate receptor
06/26/2001US6251833 Pesticide; herbicide
06/26/2001US6251420 Isoflavanoid formulations for oral administration
06/26/2001CA2214429C Ruthenium/tin bimetallic catalyst